Pharmaceuticals News and Research

RSS

Conference examines family planning benefits for health

Family planning "is one of the most cost-effective ways to prevent illness and save lives in the world's poor countries," according to health experts gathered in Addis Ababa, Ethiopia, at a conference sponsored by the Reproductive Health Supplies Coalition, GlobalPost's "Africa Emerges" blog reports.

24 Jun 2011

EMA CHMP recommends approval of linagliptin for type 2 diabetes

Boehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.

24 Jun 2011

Supreme Court sides with drug makers in two decisions

One would shield pharmaceutical companies from most lawsuits filed by people injured by taking generic drugs. The other strikes down a Vermont law that banned some commercial uses — "data mining" — of prescription data.

24 Jun 2011

Department of Defense awards Impel Phase II SBIR grant for blood-brain barrier bypass technology

Impel NeuroPharma, a medical device company whose technology is designed to enable pharmaceutical drugs to bypass the blood-brain barrier and enter the central nervous system (CNS), today announced that it was selected to receive a Phase II Small Business Investigational Research (SBIR) grant from the Department of Defense's Chemical and Biological Defense SBIR Program entitled, "Blood Brain Barrier Drug Delivery of Therapeutics for Chemical Warfare Agents."

24 Jun 2011

First Edition: June 24, 2011

In today's headlines, reports that Republicans have quit the debt-ceiling negotiations and details about how the Supreme Court sided with drug makers in two decisions.

24 Jun 2011

Galileo's advanced visual analytics platform to be launched at BIO 2011 conference

Galileo Analytics announced today that it will debut Galileo Cosmos, Galileo's advanced visual analytics platform at the BIO 2011 conference in Washington, DC, providing a powerful new dimension to Galileo's suite of analytical tools and enhancing the company's ability to mine complex sets of de-identified health data.

24 Jun 2011

Pfizer and Pain Therapeutics receive FDA Complete Response Letter for resubmission of REMOXY NDA

Pfizer and Pain Therapeutics, Inc. announced that a Complete Response Letter was received from the U.S. Food and Drug Administration (FDA) on the resubmission to the new drug application (NDA) for REMOXY® (oxycodone) Extended-Release Capsules CII. Pfizer is working to evaluate the issues described in the Complete Response Letter and plans to have further discussions with FDA around them.

24 Jun 2011

ABA honors Acorda Therapeutics president with 2011 Stevie Award

Acorda Therapeutics, Inc. announced that Ron Cohen, M.D., President and CEO of Acorda Therapeutics, was awarded the 2011 Stevie Award for Executive of the Year in the Health Products & Services category at the 9th Annual American Business Awards (ABA) ceremony held on June 20, 2011.

24 Jun 2011

Ashoka and Boehringer Ingelheim initiative to promote health

The social entrepreneurial organization Ashoka and pharmaceutical company Boehringer Ingelheim on Tuesday announced they are launching a three-year global initiative aimed at "promoting healthy individuals, families and communities by identifying and supporting the most promising solutions to challenging health problems," according to an Ashoka press release.

24 Jun 2011

Small 'antifreeze' molecules more effective in protecting proteins than larger ones

Scientists have made an important step forward in their understanding of cryoprotectants - compounds that act as natural 'antifreeze' to protect drugs, food and tissues stored at sub-zero temperatures.

24 Jun 2011

PCIB reports main results of Amphinex Phase I/II study against multiple cancers

PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today the main results of the completed Phase I/II study of the new component Amphinex in the combination productPC-A11, where Amphinex is used in combination with the cytotoxic agent bleomycin.

24 Jun 2011

Clinical trial management systems market to reach over $1.76B by 2017

It is expected that the clinical trial management systems (CTMS) market will achieve a value of $1.76 billion by 2017, according to a new report on companiesandmarkets.com.

24 Jun 2011

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Endo Pharmaceuticals announced today that it received notification from the U.S. Food and Drug Administration (FDA) that Endo's complete response to the FDA's Jan. 7, 2011 Action Letter relating to Endo's new drug application (NDA) for a new formulation of OPANA ER has been accepted.

24 Jun 2011

Ketogenic diet reduces seizures in mice through adenosine A1 receptors

Some individuals with epilepsy fail to respond to treatment with conventional drugs but benefit from consuming a ketogenic diet - a high-fat, low-carbohydrate diet similar to the more commonly known Atkins diet.

24 Jun 2011

Mylan introduces generic Entocort EC capsules for treatment of Crohn's disease

Mylan Inc. today announced that the U.S. District Court for the District of Delaware has found after trial that Mylan subsidiary Mylan Pharmaceuticals Inc. does not infringe the asserted claims of U.S. Patent No. 5,643,602 with its Abbreviated New Drug Application for Budesonide Capsules, 3 mg, the generic version of AstraZeneca's Entocort EC capsules, a treatment for Crohn's disease.

24 Jun 2011

Idera presents IMO-3100 data on preclinical model of arthritis at FOCIS 2011

Idera Pharmaceuticals, Inc. announced today the presentation of IMO-3100 mechanism of action data in a preclinical model of arthritis.

24 Jun 2011

Adeona enters agreement to begin proprietary zinc-based therapy Phase IIb trial in ALS

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that it has expanded its pipeline of proprietary zinc-based therapies to include a planned Phase IIb clinical trial of patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease.

24 Jun 2011

BioMarin to acquire Pfizer's Ireland manufacturing plant

BioMarin Pharmaceutical Inc. announced today that it has entered into a definitive agreement to acquire a bulk biologics manufacturing plant from Pfizer, located in Shanbally, Cork, Ireland.

24 Jun 2011

Orient Europharma to initiate CEL-SCI's Multikine Phase III trial in head and neck cancer

CEL-SCI Corporation announced today that its Taiwanese partner, Orient Europharma, has concluded the Site Initiation Visit for the first Taiwanese clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy. The first center is called Shin Kong Wu Ho-Su Memorial Hospital and is located in Taipei, Taiwan.

24 Jun 2011

Scil Technology receives public research grant for novel rheumatoid arthritis treatments

Scil Technology GmbH, a biopharmaceutical company with core expertise in protein drug development, formulation and analytics, today announced that it has been awarded research funding by the German Federal Ministry of Education and Research (BMBF) under BMBF’s KMU-innovativ scheme. The EUR 0.9 million grant supports Scil Technology’s research program to explore the therapeutic potential of repellent proteins for the treatment of rheumatoid arthritis (RA).

23 Jun 2011

Pharmaceuticals News and Research

Conference examines family planning benefits for health

EMA CHMP recommends approval of linagliptin for type 2 diabetes

Supreme Court sides with drug makers in two decisions

Department of Defense awards Impel Phase II SBIR grant for blood-brain barrier bypass technology

First Edition: June 24, 2011

Galileo's advanced visual analytics platform to be launched at BIO 2011 conference

Pfizer and Pain Therapeutics receive FDA Complete Response Letter for resubmission of REMOXY NDA

ABA honors Acorda Therapeutics president with 2011 Stevie Award

Ashoka and Boehringer Ingelheim initiative to promote health

Small 'antifreeze' molecules more effective in protecting proteins than larger ones

PCIB reports main results of Amphinex Phase I/II study against multiple cancers

Clinical trial management systems market to reach over $1.76B by 2017

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Ketogenic diet reduces seizures in mice through adenosine A1 receptors

Mylan introduces generic Entocort EC capsules for treatment of Crohn's disease

Idera presents IMO-3100 data on preclinical model of arthritis at FOCIS 2011

Adeona enters agreement to begin proprietary zinc-based therapy Phase IIb trial in ALS

BioMarin to acquire Pfizer's Ireland manufacturing plant

Orient Europharma to initiate CEL-SCI's Multikine Phase III trial in head and neck cancer

Scil Technology receives public research grant for novel rheumatoid arthritis treatments

Event guide: World ADC Asia eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence